|
| Entrez Id: |
1436 |
| Gene Symbol: |
CSF1R |
CSF1R
|
Neoplasms
|
0.500 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
4609 |
| Gene Symbol: |
MYC |
MYC
|
Neoplasms
|
0.500 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
1029 |
| Gene Symbol: |
CDKN2A |
CDKN2A
|
Neoplasms
|
0.500 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
472 |
| Gene Symbol: |
ATM |
ATM
|
Neoplasms
|
0.500 |
CausalMutation |
CLINVAR |
|
|
|
|
| Entrez Id: |
5925 |
| Gene Symbol: |
RB1 |
RB1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
5295 |
| Gene Symbol: |
PIK3R1 |
PIK3R1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
The structural basis of PI3K cancer mutations: from mechanism to therapy.
|
24459181 |
2014 |
|
| Entrez Id: |
324 |
| Gene Symbol: |
APC |
APC
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
5290 |
| Gene Symbol: |
PIK3CA |
PIK3CA
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
1499 |
| Gene Symbol: |
CTNNB1 |
CTNNB1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
7157 |
| Gene Symbol: |
TP53 |
TP53
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
5728 |
| Gene Symbol: |
PTEN |
PTEN
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
673 |
| Gene Symbol: |
BRAF |
BRAF
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
5295 |
| Gene Symbol: |
PIK3R1 |
PIK3R1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
6714 |
| Gene Symbol: |
SRC |
SRC
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
2778 |
| Gene Symbol: |
GNAS |
GNAS
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
2064 |
| Gene Symbol: |
ERBB2 |
ERBB2
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
7157 |
| Gene Symbol: |
TP53 |
TP53
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Mutant p53 in cancer: new functions and therapeutic opportunities.
|
24651012 |
2014 |
|
| Entrez Id: |
5979 |
| Gene Symbol: |
RET |
RET
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
3265 |
| Gene Symbol: |
HRAS |
HRAS
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
4893 |
| Gene Symbol: |
NRAS |
NRAS
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
2260 |
| Gene Symbol: |
FGFR1 |
FGFR1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
7428 |
| Gene Symbol: |
VHL |
VHL
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
6794 |
| Gene Symbol: |
STK11 |
STK11
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Prospective enterprise-level molecular genotyping of a cohort of cancer patients.
|
25157968 |
2014 |
|
| Entrez Id: |
5604 |
| Gene Symbol: |
MAP2K1 |
MAP2K1
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Discovery of a novel ERK inhibitor with activity in models of acquired resistance to BRAF and MEK inhibitors.
|
23614898 |
2013 |
|
| Entrez Id: |
2065 |
| Gene Symbol: |
ERBB3 |
ERBB3
|
Neoplasms
|
0.200 |
GeneticVariation |
CLINVAR |
Oncogenic ERBB3 mutations in human cancers.
|
23680147 |
2013 |